(Q38359973)

2 September 2017

1 reference

title

Enveloped virus-like particles as vaccines against pathogenic arboviruses (English)

1 reference

2 September 2017

0 references

Gorben P Pijlman

1

0 references

publication date

18 February 2015

1 reference

2 September 2017

published in

Biotechnology Journal

1 reference

2 September 2017

volume

10

1 reference

2 September 2017

issue

5

1 reference

2 September 2017

page(s)

659-670

1 reference

Present and future arboviral threats

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Vaccines and animal models for arboviral encephalitides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particles as a vaccine delivery system: myths and facts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particles in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particles: flexible platforms for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Applications of viral nanoparticles in medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particles produced in plants as potential vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Bioengineering virus-like particles as vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Kunjin RNA replication and applications of Kunjin replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Composition and three-dimensional architecture of the dengue virus replication and assembly sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Architecture and biogenesis of plus-strand RNA virus replication factories

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

The flavivirus precursor membrane-envelope protein complex: structure and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Incorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell Line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Evaluation of Extracellular Subviral Particles of Dengue Virus Type 2 and Japanese Encephalitis Virus Produced bySpodoptera frugiperdaCells for Use as Vaccine and Diagnostic Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Production of Japanese encephalitis virus-like particles in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Efficient production of Japanese encephalitis virus-like particles by recombinant lepidopteran insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Production of Japanese encephalitis virus-like particles using the baculovirus-insect cell system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Mouse models of dengue virus infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Flaviviruses and flavivirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Genome encapsidation by orthobunyavirus nucleoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Molecular biology of the Bunyaviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

An assembly model of rift valley Fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Single immunization with an inactivated vaccine protects sheep from Schmallenberg virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

One Health approach to Rift Valley fever vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Virus-like particle-based countermeasures against Rift Valley fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Generation and analysis of infectious virus-like particles of uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Hantavirus Gn and Gc glycoproteins self-assemble into virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Alphaviruses: population genetics and determinants of emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Infectious diseases. Crippling virus set to conquer Western Hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Salmonid alphavirus glycoprotein E2 requires low temperature and E1 for virion formation and induction of protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Salmonid alphavirus replication in mosquito cells: towards a novel vaccine production system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Heparin binding sites on Ross River virus revealed by electron cryo-microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Structural changes of envelope proteins during alphavirus fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Structural analyses at pseudo atomic resolution of Chikungunya virus and antibodies show mechanisms of neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Vaccines for viral and parasitic diseases produced with baculovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Effective chikungunya virus-like particle vaccine produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Recombinant protein vaccines produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Large-scale production and purification of VLP-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Engineering of baculovirus vectors for the manufacture of virion-free biopharmaceuticals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

West nile virus in the United States - a historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Chikungunya at the door--déjà vu all over again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Bluetongue Epidemiology in the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

'Schmallenberg virus'--a novel orthobunyavirus emerging in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400427

21 January 2018

Identifiers

DOI

10.1002/BIOT.201400427

1 reference

2 September 2017

1 reference